Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 6, 2010, Pages

  Li, Yuan ^a   Lévesque, Louis Olivier ^a   Anand Srivastava, Madhu B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Extracellular signal regulated kinase 1 2; Oxidative stress; Spontaneously hypertensive rat; Vascular smooth muscle cell proliferation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPHENYLIODONIUM SALT; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN; SUPEROXIDE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FREE RADICAL SCAVENGERS; HYPERPLASIA; HYPERTENSION; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 78649725403     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00526.2010     Document Type: Article

References (45)

1. Anand-Srivastava MB. Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta. Biochem Biophys Res Commun 117: 420-428, 1983.
2. Anand-Srivastava MB. Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein. Biochem Pharmacol 38: 489-496, 1989.
3. Anand-Srivastava MB, Franks DJ, Cantin M, Genest J. Presence of "Ra" and "P"-site receptors for adenosine coupled to adenylate cyclase in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 108: 213-219, 1982.
4. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol Cell Physiol 258: C408-C415, 1990.
5. Bouallegue A, Daou GB, Srivastava AK. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 5: 45-52, 2007.
6. Chang RS, Lotti VJ. Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 49: 1485-1490, 1991.
7. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
8. Delafontaine P, Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem 268: 16866-16870, 1993. (Pubitemid 23230006)
9. Descorbeth M, Anand-Srivastava MB. Role of growth factor receptor transactivation in high glucose-induced increased levels of Gq/11alpha and signaling in vascular smooth muscle cells. J Mol Cell Cardiol 49: 221-233.
10. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 188: 257-264, 1992.
11. Eguchi S, Hirata Y, Imai T, Marumo F. Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature. Endocrinology 132: 524-529, 1993.
12. Eguchi S, Inagami T. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91: 13-20, 2000.
13. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998.
14. El Mabrouk M, Touyz RM, Schiffrin EL. Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol Heart Circ Physiol 281: H30-H39, 2001.
15. Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 13: 831-837, 1995.
16. Fukuda N, Satoh C, Hu WY, Soma M, Kubo A, Kishioka H, Watanabe Y, Izumi Y, Kanmatsuse K. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 19: 1210-1217, 1999.
17. i protein and proliferation in A10 vascular smooth muscle cells. Can J Physiol Pharmacol 87: 1037-1045, 2009.
18. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul 1: 649-659, 1990.
19. Hamet P, Hadrava V, Kruppa U, Tremblay J. Vascular smooth muscle cell hyper-responsiveness to growth factors in hypertension. J Hypertens Suppl 6: S36-S39, 1988.
20. Hashim S, Li Y, Anand-Srivastava MB. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways. Am J Physiol Heart Circ Physiol 291: H3144-H3153, 2006.
21. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 91: 2268-2274, 1993.
22. Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI. Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106: 909-912, 2002.
23. Kanse SM, Takahashi K, Warren JB, Perera T, Porta M, Ghatei M, Bloom SR. Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol 17, Suppl 7: S113-S116, 1991.
24. Kubo A, Fukuda N, Soma M, Izumi Y, Kanmatsuse K. Inhibitory effect of an angiotensin II type 1 receptor antagonist on growth of vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 27: 58-63, 1996.
25. Kunimoto M, Soma M, Kanmatsuse K. Production of eicosanoids and angiotensin II in resistance vessels in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 25: 430-434, 1998.
26. Lappas G, Daou GB, Anand-Srivastava MB. Oxidative stress contributes to the enhanced expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 23: 2251-2261, 2005.
27. Li Y, Bou Daou G, Anand-Srivastava MB. Enhanced expression of Gia protein in SHR contributes to enhanced proliferation of vascular smooth muscle cells: implication of MAPK/PI3K signaling pathways (Abstract). Can J Cardiol 21: 1556, 2005.
28. Liao DF, Monia B, Dean N, Berk BC. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 272: 6146-6150, 1997.
29. Liau G, Chan LM. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J Biol Chem 264: 10315-10320, 1989.
30. Lu MH, Chao CF, Huang CG, Chang LT. Coculture of vascular endothelial cells and smooth muscle cells from spontaneously hypertensive rats. Clin Exp Hypertens 25: 413-425, 2003.
31. Lu MH, Chao CF, Tsai SH, Chen JY, Chang LT. Autocrine effects of endothelin on in vitro proliferation of vascular smooth muscle cells from spontaneously hypertensive and normotensive rats. Clin Exp Hypertens 28: 463-474, 2006.
32. Paquet JL, Baudouin-Legros M, Marche P, Meyer P. Enhanced proliferating activity of cultured smooth muscle cells from SHR. Am J Hypertens 2: 108-110, 1989. (Pubitemid 19055877)
33. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Buhler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 168: 1303-1310, 1990. (Pubitemid 20176022)
34. Saha S, Li Y, Lappas G, Anand-Srivastava MB. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein. J Mol Cell Cardiol 44: 336-344, 2008.
35. Saito S, Frank GD, Mifune M, Ohba M, Utsunomiya H, Motley ED, Inagami T, Eguchi S. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem 277: 44695-44700, 2002.
36. Sarzani R, Arnaldi G, Chobanian AV. Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension 17: 888-895, 1991.
37. Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 37: 108-118, 2001. (Pubitemid 32012937)
38. Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol 32, Suppl 3: S2-S13, 1998.
39. Shichiri M, Yokokura M, Marumo F, Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 20: 989-997, 2000.
40. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, Sugaya T, Hamada M, Hiwada K, Horiuchi M. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 106: 847-853, 2002.
41. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
42. Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 90: 449-455, 2005.
43. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
44. Vogelsang M, Broede-Sitz A, Schafer E, Zerkowski HR, Brodde OE. Endothelin ETA-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol 23: 344-347, 1994.
45. Wu-Wong JR, Opgenorth TJ. Endothelin and isoproterenol counterregulate cAMP and mitogen-activated protein kinases. J Cardiovasc Pharmacol 31, Suppl 1: S185-S191, 1998.